Companies: 10,795·Total market cap: $144.5T

Cingulate Inc.

Cingulate Inc.

CINGNASDAQHealthcare● Active

$4.53

+$0.04(+0.78%)

Market Cap$25395352

P/E Ratio—

52W High$11.89

52W Low$3.16

Avg Volume675K

Open$4.50

Beta-0.85

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Cingulate Inc.（CING）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · CING · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-5.02Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding5.4MShares outstanding history

Next EarningsAug 18, 2026Est.Earnings history

探索 Cingulate Inc. 数据

分析师预测$10 · Buy

股息不分红

盈利EPS $-4.13+59.51%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$22.4M▼ 35.57% YoY

202320242025

FY 2025EPS$-4.13▲ +59.51% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$27.7MEPS: $-5.02View income statement →

分析师评级与目标价

Buy6 位分析师

Strong Buy

0

Buy

5

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$10.00Low

$4.53Current

$10.00Avg Target上涨空间 120.75%

$10.00High

合计: 6 · 买入占比: 83.3%

根据过去 3 个月内 6 位华尔街分析师，CING 共识评级为 Buy，12 个月平均目标价 $10.00 （较现价 $4.53 上涨空间 120.75%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

$4.53+0.78%$25.4M #2

Allarity Therapeutics, Inc.

$1.58-1.86%$25.1M #3

BriaCell Therapeutics Corp.

$3.09+0.32%$5.8M #4

CASI Pharmaceuticals, Inc.

$0.15+3.08%$2.3M #5

Clearside Biomedical, Inc.

$0.41+0.00%$2.1M #6

Entero Therapeutics, Inc.

$2.85-5.00%$13.6M

股票表现

1D+0.78%

1W+11.58%

1M-14.04%

3M-29.55%

YTD+4.38%

1Y-0.22%

5Y-99.58%

关于 Cingulate Inc.

CEOShane J. Schaffer

IPO DateDec 8, 2021

Employees13

CountryUS

Websitecingulate.com

Cingulate Inc. is a biopharmaceutical enterprise currently in its clinical development phase, dedicated to devising therapeutic options for attention-deficit/hyperactivity disorder (ADHD). Leading its…

Biotechnology HealthcareNASDAQUS

关于股票概览与关键数据

Cingulate Inc.（CING）是 Biotechnology 行业的 Healthcare 类公司，于 Dec 8, 2021 在 NASDAQ 上市。截至最近交易日，CING 股价为 $4.53，市值约为 $25.4M。过去12个月累计回报 -0.22%，年初至今回报 +4.38%。

根据 6 位华尔街分析师，Cingulate Inc. 股票共识评级为Buy，12个月平均目标价为 $10.00。2025 财年 Cingulate Inc. 营收 —，净利润 -$22.4M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Cingulate Inc.（CING）股价为 $4.53，在 NASDAQ 上市，52周区间为 $3.16 – $11.89。

CING 最新股价CING quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议